Nicholas Galakatos, Director, 10% Owner at CATABASIS PHARMACEUTICALS INC (CATB), bought 1,995,371 shares at $12.00 ($4.5M) on 2015-06-30, disclosed to the SEC on 2015-06-30.
Open-market purchase of $4.5M CATB by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,618,676 | $0 | 0.0% |
| 2 | $12.00 | 376,695 | $4.5M | 100.0% |
| Total | $2.27 avg | 1,995,371 | $4.5M | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |